Sarepta Therapeutics, Inc.
SRPTFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
1,902
Cost of Revenue
319
Gross Profit
1,583
Gross Margin
83.2%
Operating Income
218
Operating Margin
11.5%
Net Income
235
Net Margin
12.4%
EPS (Basic)
$2.47
EPS (Diluted)
$2.34
EBITDA
333
EBITDA Margin
17.5%
2023
12/31/2023
Revenue
1,243
Cost of Revenue
150
Gross Profit
1,093
Gross Margin
87.9%
Operating Income
-268
Operating Margin
-21.5%
Net Income
-536
Net Margin
-43.1%
EPS (Basic)
$-5.80
EPS (Diluted)
$-5.80
EBITDA
-439
EBITDA Margin
-35.3%
2022
12/31/2022
Revenue
933
Cost of Revenue
140
Gross Profit
793
Gross Margin
85.0%
Operating Income
-536
Operating Margin
-57.5%
Net Income
-703
Net Margin
-75.4%
EPS (Basic)
$-8.03
EPS (Diluted)
$-8.03
EBITDA
-582
EBITDA Margin
-62.4%
2021
12/31/2021
Revenue
702
Cost of Revenue
97
Gross Profit
605
Gross Margin
86.2%
Operating Income
-460
Operating Margin
-65.5%
Net Income
-419
Net Margin
-59.7%
EPS (Basic)
$-5.15
EPS (Diluted)
$-5.15
EBITDA
-317
EBITDA Margin
-45.2%
2020
12/31/2020
Revenue
540
Cost of Revenue
63
Gross Profit
477
Gross Margin
88.3%
Operating Income
-564
Operating Margin
-104.5%
Net Income
-554
Net Margin
-102.6%
EPS (Basic)
$-7.11
EPS (Diluted)
$-7.11
EBITDA
-453
EBITDA Margin
-83.9%